Bio Spectrum Magazine - April 2021Add to Favorites

Bio Spectrum Magazine - April 2021Add to Favorites

Go Unlimited with Magzter GOLD

Read Bio Spectrum along with 8,500+ other magazines & newspapers with just one subscription  View catalog

1 Month $9.99

1 Year$99.99 $49.99


Save 50% Hurry, Offer Ends in 8 Days

Subscribe only to Bio Spectrum

1 Year$11.88 $7.99

Save 33% Memorial Day Sale!. ends on June 1, 2024

Buy this issue $0.99

Gift Bio Spectrum

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy


Digital Subscription.Instant Access.

Digital Subscription
Instant Access

Verified Secure Payment

Verified Secure

In this issue

BioSpectrum Excellence Awards 2020

Jury headed by Dr Renu Swarup decides the winners.
BioSpectrum Excellence Awards which had been presented for the last several years has earned a reputation to be the most prestigious awards in the sector. One important reason for that, among others, is the transparent process of selection. The personality and product awards are finalised by a panel of eminent juries.

BioSpectrum honours INDUSTRY STALWARTS

It is time to celebrate the outstanding contribution and achievements of the Indian Bio Sciences industry leaders and organisations over the past one year.

BioSpectrum honours INDUSTRY STALWARTS

4 mins

King Of Vaccines Protecting Children From Birth Onwards

Son of a horse breeder, Cyrus Poonawalla founded Serum Institute of India (SII) in 1966 in Pune when he was just 22 years and got married to Villoo. Over the years, his passion of offering affordable vaccines to the world has motivated to build SII into one of the world’s largest vaccine makers.

King Of Vaccines Protecting Children From Birth Onwards

2 mins

Building On Biologics Business Growth

In 1990’s when Hasmukh K Chudgar, founder of Intas Pharmaceuticals handed over the company to his sons Binish, Nimish and Urmish, the company’s turnover was less than $1 million.

Building On Biologics Business Growth

2 mins

“We are particularly looking forward to increasing our business in India”

Emerging from the Institute of Cell Culture Technology at Bielefeld University, Germany, in 2009, Xell AG (formerly TeutoCell AG), has grown to become an independent and privately financed biotech company dedicated to cutting-edge innovation and developing expertise. With more than 20 years of hands-on experience in cell culture technology, Xell has drawn from its academic and technological knowledge to become a key partner in the design and distribution of cell culture solutions. The company is currently serving the Indian market through its partnership with Navi Mumbai-based Rane Rao Reshamia Laboratories. BioSpectrum interacted with Prof. Thomas Noll, Chairman, Supervisory Board, Xell AG, Germany to find out more about the company’s plans for 2021 and beyond. Edited excerpts;

“We are particularly looking forward to increasing our business in India”

5 mins

Read all stories from Bio Spectrum

Bio Spectrum Magazine Description:

PublisherMM Activ Sci-Tech Communication




India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only